Fewer Men Estimated to Die From Prostate Cancer January 26, 2016 Washington, D.C. – Advances in the treatment of prostate cancer have lead to a steady decline in deaths from the disease. Recent statistics show that an estimated 26,120 men will die of prostate cancer in 2016, a 5 percent drop from the 2015 estimate. Based on these facts, a man will lose his prostate cancer battle every 20 minutes.“Advances in treatment have saved lives, increased survival rates among all stages of disease, and given thousands of families hope. ZERO is proud of our critical work with our advocates and partners to support research for new treatments, and we applaud the great work done by researchers, doctors, caretakers, and patients to save lives and stop pain and suffering,” said ZERO CEO Jamie Bearse. “But more needs to be done to help men and families. Detection rates have fallen significantly in recent years due to the United States Preventive Services Task Force recommendation against PSA testing, and this decision may lead to an increasing number of patients being diagnosed in the late stages of the disease, severely limiting their options for treatment.”According to the American Cancer Society’s Cancer Facts & Figures 2016:An estimated 180,890 men will be diagnosed with prostate cancer in 2016, an 18 percent decline from 2015 estimates.The ten states with the highest incidence rates include DC, Louisiana, New Jersey, Utah, Delaware, New York, Georgia, Mississippi, Arkansas, and Michigan.The highest mortality rates can be found in DC, Mississippi, Alabama, South Carolina, Idaho, Georgia, Louisiana, North Carolina, Montana, and Utah.The overall five-year survival rate still holds steady at nearly 100 percent.For men diagnosed at an advanced stage of disease, the five-year survival rate is 28 percent.ZERO urges continued focus on advancing diagnostic tools and technology to find prostate cancer early and distinguish aggressive disease from slow growing disease. While the decrease in the number of deaths from the disease is a promising statistic, all men and their families need to know the risks of prostate cancer and be fully informed about early detection, testing, and treatment options. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org Press Release
Washington, D.C. – Advances in the treatment of prostate cancer have lead to a steady decline in deaths from the disease. Recent statistics show that an estimated 26,120 men will die of prostate cancer in 2016, a 5 percent drop from the 2015 estimate. Based on these facts, a man will lose his prostate cancer battle every 20 minutes.“Advances in treatment have saved lives, increased survival rates among all stages of disease, and given thousands of families hope. ZERO is proud of our critical work with our advocates and partners to support research for new treatments, and we applaud the great work done by researchers, doctors, caretakers, and patients to save lives and stop pain and suffering,” said ZERO CEO Jamie Bearse. “But more needs to be done to help men and families. Detection rates have fallen significantly in recent years due to the United States Preventive Services Task Force recommendation against PSA testing, and this decision may lead to an increasing number of patients being diagnosed in the late stages of the disease, severely limiting their options for treatment.”According to the American Cancer Society’s Cancer Facts & Figures 2016:An estimated 180,890 men will be diagnosed with prostate cancer in 2016, an 18 percent decline from 2015 estimates.The ten states with the highest incidence rates include DC, Louisiana, New Jersey, Utah, Delaware, New York, Georgia, Mississippi, Arkansas, and Michigan.The highest mortality rates can be found in DC, Mississippi, Alabama, South Carolina, Idaho, Georgia, Louisiana, North Carolina, Montana, and Utah.The overall five-year survival rate still holds steady at nearly 100 percent.For men diagnosed at an advanced stage of disease, the five-year survival rate is 28 percent.ZERO urges continued focus on advancing diagnostic tools and technology to find prostate cancer early and distinguish aggressive disease from slow growing disease. While the decrease in the number of deaths from the disease is a promising statistic, all men and their families need to know the risks of prostate cancer and be fully informed about early detection, testing, and treatment options.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
